Structure

Physi-Chem Properties

Molecular Weight:  400.15
Volume:  403.839
LogP:  5.848
LogD:  2.502
LogS:  -4.024
# Rotatable Bonds:  4
TPSA:  128.2
# H-Bond Aceptor:  7
# H-Bond Donor:  4
# Rings:  3
# Heavy Atoms:  7

MedChem Properties

QED Drug-Likeness Score:  0.467
Synthetic Accessibility Score:  3.202
Fsp3:  0.364
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.103
MDCK Permeability:  1.0487301551620476e-05
Pgp-inhibitor:  0.13
Pgp-substrate:  0.004
Human Intestinal Absorption (HIA):  0.419
20% Bioavailability (F20%):  0.004
30% Bioavailability (F30%):  0.001

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.003
Plasma Protein Binding (PPB):  97.69879150390625%
Volume Distribution (VD):  0.407
Pgp-substrate:  2.127363681793213%

ADMET: Metabolism

CYP1A2-inhibitor:  0.736
CYP1A2-substrate:  0.893
CYP2C19-inhibitor:  0.111
CYP2C19-substrate:  0.169
CYP2C9-inhibitor:  0.777
CYP2C9-substrate:  0.55
CYP2D6-inhibitor:  0.013
CYP2D6-substrate:  0.164
CYP3A4-inhibitor:  0.089
CYP3A4-substrate:  0.171

ADMET: Excretion

Clearance (CL):  2.101
Half-life (T1/2):  0.087

ADMET: Toxicity

hERG Blockers:  0.001
Human Hepatotoxicity (H-HT):  0.104
Drug-inuced Liver Injury (DILI):  0.989
AMES Toxicity:  0.536
Rat Oral Acute Toxicity:  0.069
Maximum Recommended Daily Dose:  0.484
Skin Sensitization:  0.794
Carcinogencity:  0.261
Eye Corrosion:  0.003
Eye Irritation:  0.362
Respiratory Toxicity:  0.162

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC172182

Natural Product ID:  NPC172182
Common Name*:   1,3,7,9-Tetrahydroxy-4,6-Dimethyl-2,8-Di(2-Methylpropionyl)Dibenzofuran
IUPAC Name:   2-methyl-1-[1,3,7,9-tetrahydroxy-4,6-dimethyl-8-(2-methylpropanoyl)dibenzofuran-2-yl]propan-1-one
Synonyms:  
Standard InCHIKey:  YZDDRPAVFBMBPD-UHFFFAOYSA-N
Standard InCHI:  InChI=1S/C22H24O7/c1-7(2)15(23)13-17(25)9(5)21-11(19(13)27)12-20(28)14(16(24)8(3)4)18(26)10(6)22(12)29-21/h7-8,25-28H,1-6H3
SMILES:  CC(C(=O)c1c(O)c(C)c2c(c1O)c1c(O)c(C(=O)C(C)C)c(c(c1o2)C)O)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL2146934
PubChem CID:   71456371
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0000301] Benzofurans
        • [CHEMONTID:0000015] Dibenzofurans

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO32572 pilidostigma glabrum Species n.a. n.a. n.a. Australian n.a. PMID[22934671]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT113 Cell Line RAW264.7 Mus musculus IC50 = 3400.0 nM PMID[488813]
NPT886 Cell Line NIH3T3 Mus musculus IC50 = 4500.0 nM PMID[488813]
NPT113 Cell Line RAW264.7 Mus musculus ED50 = 12.0 uM PMID[488813]
NPT886 Cell Line NIH3T3 Mus musculus ED50 = 15.3 uM PMID[488813]
NPT113 Cell Line RAW264.7 Mus musculus Selectivity Index = 3.53 n.a. PMID[488813]
NPT886 Cell Line NIH3T3 Mus musculus Selectivity Index = 3.4 n.a. PMID[488813]
NPT16 Organism Staphylococcus aureus Staphylococcus aureus MIC = 2700.0 nM PMID[488813]
NPT16 Organism Staphylococcus aureus Staphylococcus aureus MBC = 11.4 uM PMID[488813]
NPT16 Organism Staphylococcus aureus Staphylococcus aureus MBC = 5.7 uM PMID[488813]
NPT17 Organism Staphylococcus epidermidis Staphylococcus epidermidis MIC = 2700.0 nM PMID[488813]
NPT17 Organism Staphylococcus epidermidis Staphylococcus epidermidis MBC = 22.7 uM PMID[488813]
NPT35 Others n.a. Activity = 1451.0 umol/g PMID[488813]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC172182 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC262935
1.0 High Similarity NPC251182
0.9783 High Similarity NPC96791
0.9783 High Similarity NPC470636
0.9783 High Similarity NPC226942
0.9257 High Similarity NPC474386
0.911 High Similarity NPC226644
0.911 High Similarity NPC178202
0.911 High Similarity NPC37226
0.9054 High Similarity NPC5871
0.9048 High Similarity NPC230713
0.9048 High Similarity NPC78335
0.9041 High Similarity NPC135325
0.9034 High Similarity NPC210826
0.9021 High Similarity NPC111201
0.9013 High Similarity NPC472346
0.8993 High Similarity NPC235333
0.8993 High Similarity NPC213608
0.8993 High Similarity NPC1477
0.8986 High Similarity NPC170169
0.8973 High Similarity NPC130581
0.8973 High Similarity NPC12148
0.8951 High Similarity NPC164697
0.8951 High Similarity NPC82920
0.8951 High Similarity NPC289660
0.8933 High Similarity NPC213936
0.8933 High Similarity NPC148938
0.8933 High Similarity NPC297531
0.8926 High Similarity NPC263676
0.8904 High Similarity NPC51641
0.8904 High Similarity NPC300267
0.8897 High Similarity NPC225884
0.8882 High Similarity NPC40583
0.8881 High Similarity NPC270913
0.8874 High Similarity NPC160015
0.8874 High Similarity NPC180924
0.8874 High Similarity NPC247677
0.8867 High Similarity NPC183874
0.8867 High Similarity NPC472462
0.8859 High Similarity NPC58668
0.8859 High Similarity NPC23668
0.8859 High Similarity NPC193976
0.8859 High Similarity NPC106372
0.8859 High Similarity NPC116604
0.8851 High Similarity NPC296030
0.8851 High Similarity NPC39929
0.8851 High Similarity NPC221868
0.8851 High Similarity NPC37208
0.8844 High Similarity NPC17816
0.8836 High Similarity NPC230943
0.8819 High Similarity NPC28337
0.8816 High Similarity NPC96342
0.8816 High Similarity NPC296957
0.8816 High Similarity NPC65504
0.8816 High Similarity NPC260902
0.8816 High Similarity NPC246647
0.8816 High Similarity NPC212967
0.8816 High Similarity NPC164110
0.8816 High Similarity NPC268360
0.8808 High Similarity NPC198490
0.88 High Similarity NPC207624
0.88 High Similarity NPC142308
0.88 High Similarity NPC253872
0.8792 High Similarity NPC167576
0.8792 High Similarity NPC472406
0.8784 High Similarity NPC272194
0.8774 High Similarity NPC109180
0.8767 High Similarity NPC302181
0.8759 High Similarity NPC157497
0.8759 High Similarity NPC285659
0.8759 High Similarity NPC81337
0.8758 High Similarity NPC244750
0.8758 High Similarity NPC476349
0.8758 High Similarity NPC476350
0.8733 High Similarity NPC115324
0.8716 High Similarity NPC308200
0.871 High Similarity NPC219861
0.8707 High Similarity NPC155144
0.8705 High Similarity NPC186628
0.8701 High Similarity NPC260296
0.8701 High Similarity NPC115432
0.8699 High Similarity NPC472344
0.8699 High Similarity NPC53192
0.869 High Similarity NPC469818
0.8684 High Similarity NPC99199
0.8675 High Similarity NPC67654
0.8667 High Similarity NPC476509
0.8658 High Similarity NPC39195
0.8658 High Similarity NPC145467
0.8654 High Similarity NPC472581
0.8652 High Similarity NPC285054
0.8643 High Similarity NPC279566
0.8621 High Similarity NPC240305
0.8618 High Similarity NPC72370
0.8618 High Similarity NPC122365
0.8611 High Similarity NPC255801
0.8611 High Similarity NPC322301
0.8609 High Similarity NPC156244
0.86 High Similarity NPC317492
0.86 High Similarity NPC471114
0.8591 High Similarity NPC198427
0.859 High Similarity NPC193998
0.8581 High Similarity NPC98926
0.8581 High Similarity NPC311144
0.8581 High Similarity NPC326500
0.8581 High Similarity NPC304839
0.8581 High Similarity NPC220582
0.8581 High Similarity NPC271288
0.8562 High Similarity NPC477272
0.8553 High Similarity NPC148480
0.8552 High Similarity NPC474504
0.8552 High Similarity NPC470671
0.8552 High Similarity NPC183639
0.8552 High Similarity NPC474487
0.8552 High Similarity NPC199458
0.8552 High Similarity NPC254168
0.8552 High Similarity NPC248995
0.8552 High Similarity NPC272844
0.8552 High Similarity NPC470672
0.8543 High Similarity NPC321896
0.8543 High Similarity NPC471115
0.8543 High Similarity NPC29777
0.8543 High Similarity NPC148423
0.8543 High Similarity NPC135303
0.8543 High Similarity NPC476185
0.8542 High Similarity NPC470982
0.8542 High Similarity NPC470983
0.8535 High Similarity NPC155640
0.8535 High Similarity NPC159508
0.8533 High Similarity NPC168085
0.8526 High Similarity NPC30655
0.8526 High Similarity NPC45124
0.8526 High Similarity NPC74854
0.8526 High Similarity NPC304387
0.8523 High Similarity NPC299011
0.8523 High Similarity NPC477955
0.8523 High Similarity NPC82534
0.8521 High Similarity NPC15834
0.8521 High Similarity NPC215875
0.8514 High Similarity NPC24821
0.8514 High Similarity NPC9117
0.8514 High Similarity NPC112749
0.8514 High Similarity NPC190637
0.8514 High Similarity NPC212932
0.8514 High Similarity NPC293053
0.8514 High Similarity NPC113770
0.8514 High Similarity NPC11700
0.8506 High Similarity NPC137100
0.8503 High Similarity NPC282300
0.8503 High Similarity NPC476508
0.8503 High Similarity NPC74397
0.8493 Intermediate Similarity NPC216978
0.8493 Intermediate Similarity NPC220062
0.8493 Intermediate Similarity NPC477956
0.8493 Intermediate Similarity NPC217186
0.8493 Intermediate Similarity NPC301217
0.8493 Intermediate Similarity NPC241975
0.8493 Intermediate Similarity NPC96565
0.8493 Intermediate Similarity NPC19476
0.8493 Intermediate Similarity NPC55018
0.8493 Intermediate Similarity NPC53181
0.8493 Intermediate Similarity NPC303633
0.8491 Intermediate Similarity NPC286230
0.8491 Intermediate Similarity NPC476459
0.8491 Intermediate Similarity NPC253730
0.8487 Intermediate Similarity NPC290671
0.8483 Intermediate Similarity NPC62735
0.8483 Intermediate Similarity NPC474624
0.8483 Intermediate Similarity NPC138047
0.8483 Intermediate Similarity NPC131782
0.8481 Intermediate Similarity NPC169471
0.8481 Intermediate Similarity NPC329215
0.8481 Intermediate Similarity NPC37183
0.8481 Intermediate Similarity NPC204088
0.8481 Intermediate Similarity NPC136641
0.8481 Intermediate Similarity NPC259007
0.8472 Intermediate Similarity NPC101752
0.8471 Intermediate Similarity NPC3448
0.8471 Intermediate Similarity NPC477239
0.8462 Intermediate Similarity NPC16197
0.8456 Intermediate Similarity NPC470673
0.8456 Intermediate Similarity NPC470674
0.8456 Intermediate Similarity NPC1886
0.8456 Intermediate Similarity NPC117716
0.8456 Intermediate Similarity NPC234629
0.8456 Intermediate Similarity NPC216538
0.8456 Intermediate Similarity NPC273538
0.8456 Intermediate Similarity NPC224714
0.8456 Intermediate Similarity NPC311741
0.8456 Intermediate Similarity NPC196137
0.8456 Intermediate Similarity NPC303185
0.8456 Intermediate Similarity NPC184649
0.8456 Intermediate Similarity NPC470890
0.8452 Intermediate Similarity NPC270044
0.8446 Intermediate Similarity NPC473042
0.8446 Intermediate Similarity NPC200694
0.8446 Intermediate Similarity NPC470556
0.8446 Intermediate Similarity NPC144499
0.8442 Intermediate Similarity NPC469934
0.8435 Intermediate Similarity NPC172986

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC172182 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8881 High Similarity NPD2800 Approved
0.8456 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.8442 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.8333 Intermediate Similarity NPD6651 Approved
0.8333 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.8231 Intermediate Similarity NPD2344 Approved
0.8217 Intermediate Similarity NPD3749 Approved
0.8212 Intermediate Similarity NPD2533 Approved
0.8212 Intermediate Similarity NPD2534 Approved
0.8212 Intermediate Similarity NPD2532 Approved
0.8129 Intermediate Similarity NPD7411 Suspended
0.8121 Intermediate Similarity NPD1243 Approved
0.8105 Intermediate Similarity NPD920 Approved
0.8063 Intermediate Similarity NPD6959 Discontinued
0.8025 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.8025 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.8013 Intermediate Similarity NPD2309 Approved
0.7987 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7987 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7945 Intermediate Similarity NPD1240 Approved
0.7933 Intermediate Similarity NPD1549 Phase 2
0.7857 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7852 Intermediate Similarity NPD1510 Phase 2
0.7838 Intermediate Similarity NPD1607 Approved
0.7834 Intermediate Similarity NPD4380 Phase 2
0.7812 Intermediate Similarity NPD3882 Suspended
0.7812 Intermediate Similarity NPD7768 Phase 2
0.78 Intermediate Similarity NPD2796 Approved
0.7799 Intermediate Similarity NPD7819 Suspended
0.7799 Intermediate Similarity NPD2801 Approved
0.7792 Intermediate Similarity NPD1511 Approved
0.7778 Intermediate Similarity NPD5494 Approved
0.7764 Intermediate Similarity NPD7075 Discontinued
0.7763 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7758 Intermediate Similarity NPD7473 Discontinued
0.7738 Intermediate Similarity NPD6559 Discontinued
0.7736 Intermediate Similarity NPD1934 Approved
0.7733 Intermediate Similarity NPD2799 Discontinued
0.773 Intermediate Similarity NPD1247 Approved
0.7727 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7697 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7692 Intermediate Similarity NPD1512 Approved
0.7688 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7683 Intermediate Similarity NPD6232 Discontinued
0.7636 Intermediate Similarity NPD3926 Phase 2
0.7632 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.7625 Intermediate Similarity NPD6801 Discontinued
0.7597 Intermediate Similarity NPD3750 Approved
0.7588 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7576 Intermediate Similarity NPD5710 Approved
0.7576 Intermediate Similarity NPD5711 Approved
0.7564 Intermediate Similarity NPD6799 Approved
0.7547 Intermediate Similarity NPD3226 Approved
0.7546 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD6599 Discontinued
0.75 Intermediate Similarity NPD3818 Discontinued
0.7485 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7485 Intermediate Similarity NPD6166 Phase 2
0.7485 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7456 Intermediate Similarity NPD7286 Phase 2
0.7456 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7452 Intermediate Similarity NPD7390 Discontinued
0.7451 Intermediate Similarity NPD2935 Discontinued
0.745 Intermediate Similarity NPD2313 Discontinued
0.7423 Intermediate Similarity NPD2296 Approved
0.7403 Intermediate Similarity NPD1471 Phase 3
0.7396 Intermediate Similarity NPD7893 Clinical (unspecified phase)
0.7394 Intermediate Similarity NPD919 Approved
0.7386 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7381 Intermediate Similarity NPD2403 Approved
0.7378 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7368 Intermediate Similarity NPD5953 Discontinued
0.7338 Intermediate Similarity NPD6100 Approved
0.7338 Intermediate Similarity NPD6099 Approved
0.7338 Intermediate Similarity NPD1551 Phase 2
0.7333 Intermediate Similarity NPD3268 Approved
0.7333 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7333 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.733 Intermediate Similarity NPD4287 Approved
0.7317 Intermediate Similarity NPD3817 Phase 2
0.729 Intermediate Similarity NPD2346 Discontinued
0.7273 Intermediate Similarity NPD3748 Approved
0.7262 Intermediate Similarity NPD7229 Phase 3
0.7256 Intermediate Similarity NPD1465 Phase 2
0.7251 Intermediate Similarity NPD5844 Phase 1
0.7209 Intermediate Similarity NPD7074 Phase 3
0.72 Intermediate Similarity NPD4908 Phase 1
0.716 Intermediate Similarity NPD6808 Phase 2
0.7152 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7152 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7151 Intermediate Similarity NPD7054 Approved
0.7127 Intermediate Similarity NPD4361 Phase 2
0.7127 Intermediate Similarity NPD4362 Clinical (unspecified phase)
0.7124 Intermediate Similarity NPD943 Approved
0.7114 Intermediate Similarity NPD1203 Approved
0.711 Intermediate Similarity NPD7472 Approved
0.711 Intermediate Similarity NPD1729 Discontinued
0.7105 Intermediate Similarity NPD1699 Clinical (unspecified phase)
0.7091 Intermediate Similarity NPD6280 Approved
0.7091 Intermediate Similarity NPD6279 Approved
0.7089 Intermediate Similarity NPD2654 Approved
0.7083 Intermediate Similarity NPD5537 Clinical (unspecified phase)
0.7072 Intermediate Similarity NPD4363 Phase 3
0.7072 Intermediate Similarity NPD4360 Phase 2
0.7069 Intermediate Similarity NPD6797 Phase 2
0.7067 Intermediate Similarity NPD2798 Approved
0.7044 Intermediate Similarity NPD4628 Phase 3
0.7029 Intermediate Similarity NPD7251 Discontinued
0.7022 Intermediate Similarity NPD8434 Phase 2
0.7006 Intermediate Similarity NPD5402 Approved
0.7 Intermediate Similarity NPD2797 Approved
0.7 Intermediate Similarity NPD3267 Approved
0.7 Intermediate Similarity NPD3266 Approved
0.6994 Remote Similarity NPD5403 Approved
0.6993 Remote Similarity NPD3764 Approved
0.6989 Remote Similarity NPD7808 Phase 3
0.6989 Remote Similarity NPD4338 Clinical (unspecified phase)
0.6975 Remote Similarity NPD7004 Clinical (unspecified phase)
0.6971 Remote Similarity NPD7993 Clinical (unspecified phase)
0.6968 Remote Similarity NPD5124 Phase 1
0.6968 Remote Similarity NPD5123 Clinical (unspecified phase)
0.6959 Remote Similarity NPD1610 Phase 2
0.6946 Remote Similarity NPD5761 Phase 2
0.6946 Remote Similarity NPD5760 Phase 2
0.6928 Remote Similarity NPD4625 Phase 3
0.6928 Remote Similarity NPD7615 Clinical (unspecified phase)
0.6913 Remote Similarity NPD1608 Approved
0.6913 Remote Similarity NPD9717 Approved
0.6899 Remote Similarity NPD5404 Approved
0.6899 Remote Similarity NPD5406 Approved
0.6899 Remote Similarity NPD5405 Approved
0.6899 Remote Similarity NPD5408 Approved
0.689 Remote Similarity NPD6980 Clinical (unspecified phase)
0.6882 Remote Similarity NPD7501 Clinical (unspecified phase)
0.6871 Remote Similarity NPD5401 Approved
0.6863 Remote Similarity NPD6832 Phase 2
0.6855 Remote Similarity NPD6003 Clinical (unspecified phase)
0.6855 Remote Similarity NPD6005 Phase 3
0.6855 Remote Similarity NPD6004 Phase 3
0.6855 Remote Similarity NPD6006 Clinical (unspecified phase)
0.6855 Remote Similarity NPD6002 Phase 3
0.6846 Remote Similarity NPD422 Phase 1
0.6835 Remote Similarity NPD7033 Discontinued
0.6832 Remote Similarity NPD7003 Approved
0.6807 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6802 Remote Similarity NPD7199 Phase 2
0.6786 Remote Similarity NPD37 Approved
0.6784 Remote Similarity NPD6234 Discontinued
0.6776 Remote Similarity NPD1164 Approved
0.6768 Remote Similarity NPD7422 Clinical (unspecified phase)
0.6765 Remote Similarity NPD4966 Approved
0.6765 Remote Similarity NPD4965 Approved
0.6765 Remote Similarity NPD4967 Phase 2
0.676 Remote Similarity NPD8313 Approved
0.676 Remote Similarity NPD8312 Approved
0.6755 Remote Similarity NPD4749 Approved
0.6752 Remote Similarity NPD230 Phase 1
0.6752 Remote Similarity NPD447 Suspended
0.6742 Remote Similarity NPD3658 Clinical (unspecified phase)
0.6733 Remote Similarity NPD1547 Clinical (unspecified phase)
0.673 Remote Similarity NPD651 Clinical (unspecified phase)
0.673 Remote Similarity NPD4308 Phase 3
0.6724 Remote Similarity NPD7184 Clinical (unspecified phase)
0.672 Remote Similarity NPD8090 Clinical (unspecified phase)
0.6711 Remote Similarity NPD3225 Approved
0.6711 Remote Similarity NPD17 Approved
0.6707 Remote Similarity NPD7458 Discontinued
0.6707 Remote Similarity NPD6143 Clinical (unspecified phase)
0.6706 Remote Similarity NPD4288 Approved
0.6689 Remote Similarity NPD3972 Approved
0.6689 Remote Similarity NPD1548 Phase 1
0.6688 Remote Similarity NPD1530 Clinical (unspecified phase)
0.6686 Remote Similarity NPD4575 Clinical (unspecified phase)
0.6685 Remote Similarity NPD3269 Clinical (unspecified phase)
0.6685 Remote Similarity NPD7879 Clinical (unspecified phase)
0.6667 Remote Similarity NPD6585 Discontinued
0.6667 Remote Similarity NPD1470 Approved
0.6667 Remote Similarity NPD8397 Clinical (unspecified phase)
0.6648 Remote Similarity NPD3446 Phase 1
0.6646 Remote Similarity NPD6355 Discontinued
0.6646 Remote Similarity NPD1899 Clinical (unspecified phase)
0.6645 Remote Similarity NPD1529 Clinical (unspecified phase)
0.6644 Remote Similarity NPD4196 Clinical (unspecified phase)
0.6627 Remote Similarity NPD5889 Approved
0.6627 Remote Similarity NPD5890 Approved
0.6623 Remote Similarity NPD1201 Approved
0.661 Remote Similarity NPD3751 Discontinued
0.6605 Remote Similarity NPD2424 Discontinued
0.6601 Remote Similarity NPD1876 Approved
0.6598 Remote Similarity NPD8151 Discontinued
0.6581 Remote Similarity NPD2861 Phase 2
0.6571 Remote Similarity NPD3787 Discontinued
0.6561 Remote Similarity NPD6410 Clinical (unspecified phase)
0.6561 Remote Similarity NPD1296 Phase 2
0.6561 Remote Similarity NPD411 Approved
0.6556 Remote Similarity NPD6104 Discontinued
0.6554 Remote Similarity NPD7340 Approved
0.655 Remote Similarity NPD8455 Phase 2
0.6527 Remote Similarity NPD5049 Phase 3
0.6517 Remote Similarity NPD7177 Discontinued

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data